- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 6, 2025 | 167.23M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 176.3M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 168.1M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 163.2M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 170.4M sh |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $157.7M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $156.4M |
| Capex | Q3 2025 · Sep 30, 2025 | $64M |
| Capex | Q3 2025 · Sep 30, 2024 | $59.9M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $189.5M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $174.7M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $2.58B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $2.48B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $10M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $63M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $46.9M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $542.6M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $539.1M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $649M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $618.2M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $628.7M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $577.3M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $510.7M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $520.8M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $4.53B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $4.43B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $404.9M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $385.8M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $5.21B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $5.22B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.29 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.26 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.20 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $1.08 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.29 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.26 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.20 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $1.10 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $105.2M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $330.5M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $108.7M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $338.3M |
| Net Income | Q3 2025 · Sep 30, 2025 | $51.3M |
| Net Income | Q3 2025 · Sep 30, 2025 | $50.2M |
| Net Income | Q3 2025 · Sep 30, 2024 | $34.6M |
| Net Income | Q3 2025 · Sep 30, 2024 | $184.2M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $89.9M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $160M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $71.3M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $314.4M |
| Revenue | Q3 2025 · Sep 30, 2025 | $467.5M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.32B |
| Revenue | Q3 2025 · Sep 30, 2024 | $451.9M |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.34B |